The locus ceruleus norepinephrine system

The locus ceruleus (LC) contains norepinephrine (NE)-synthesizing neurons that send diffuse projections throughout the CNS. The LC-NE system has a major role in arousal, attention, and stress response. In the brain, NE may also contribute to long-term synaptic plasticity, pain modulation, motor control, energy homeostasis, and control of local blood blow. The LC is severely affected in neurodegenerative disorders such as Alzheimer disease (AD) and Parkinson disease (PD). Dysregulation of LC-NE system has been implicated in sleep and arousal disorders, attention deficit hyperactivity disorder, and posttraumatic stress disorder and constitutes a target for pharmacologic treatment of these conditions. The neurobiology of the LC–noradrenergic system has been the subject of several excellent reviews.1–9 The LC is a cluster of NE-containing neurons located in the upper dorsolateral pontine tegmentum (figure 1). These neurons have extensively branched axons that project throughout the neuraxis and provide the sole source of NE to the neocortex, hippocampus, cerebellum, and most of the thalamus.1,2 Despite its widespread distribution, noradrenergic innervation shows regional specificity. For example, brain areas involved in spatial attention (such as the prefrontal and parietal cortices) receive particularly dense LC-NE inputs. In general, individual LC neurons send axon collaterals to multiple targets that process the same sensory information. Norepinephrine is released both at typical synapses and at nonsynaptic release sites; extrasynaptic NE mediates paracrine effects on neurons, glial cells, and microvessels.1–4,8 Figure 1 Anatomic organization of the locus ceruleus–norepinephrine system The norepinephrine (NE) neurons of the locus ceruleus (LC) are located in the upper dorsolateral pontine tegmentum and can be identified by their immunoreactivity for tyrosine hydroxylase, the rate-limiting enzyme for catecholamine synthesis. These neurons have extensively branched axons that project throughout the neuraxis and provide the sole source of NE to the neocortex, hippocampus, cerebellum, and most of the thalamus. Modified, …

[1]  Evelyne Balteau,et al.  The Locus Ceruleus Is Involved in the Successful Retrieval of Emotional Memories in Humans , 2006, The Journal of Neuroscience.

[2]  Chris Zarow,et al.  Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. , 2003, Archives of neurology.

[3]  P. McNamara,et al.  Neuropharmacological Treatment of Mental Dysfunction in Parkinson’s Disease , 2006, Behavioural neurology.

[4]  Jun Lu,et al.  The pontine REM switch: past and present , 2007, The Journal of physiology.

[5]  K. Rommelfanger,et al.  Norepinephrine: The redheaded stepchild of Parkinson's disease. , 2007, Biochemical pharmacology.

[6]  D. McCormick,et al.  Neurotransmitter actions in the thalamus and cerebral cortex. , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[7]  S. Sara The locus coeruleus and noradrenergic modulation of cognition , 2009, Nature Reviews Neuroscience.

[8]  E. V. Van Bockstaele,et al.  Convergent regulation of locus coeruleus activity as an adaptive response to stress. , 2008, European journal of pharmacology.

[9]  Mathias Hoehn,et al.  Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic Mice , 2006, The Journal of Neuroscience.

[10]  C. Berridge,et al.  The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.

[11]  Angela J. Yu,et al.  Phasic norepinephrine: A neural interrupt signal for unexpected events , 2006, Network.

[12]  S. Kalinin,et al.  Noradrenaline deficiency in brain increases β-amyloid plaque burden in an animal model of Alzheimer's disease , 2007, Neurobiology of Aging.

[13]  F. Bloom Chemically coded transmitter systems. , 1979, Progress in brain research.

[14]  Wei He,et al.  Locus coeruleus alpha-adrenergic-mediated activation of cortical astrocytes in vivo. , 2008, Cerebral cortex.

[15]  Elisabet Englund,et al.  Locus ceruleus degeneration is ubiquitous in Alzheimer’s disease: Possible implications for diagnosis and treatment , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[16]  D. Weinshenker,et al.  Functional consequences of locus coeruleus degeneration in Alzheimer's disease. , 2008, Current Alzheimer research.

[17]  E. Peskind,et al.  Compensatory Changes in the Noradrenergic Nervous System in the Locus Ceruleus and Hippocampus of Postmortem Subjects with Alzheimer's Disease and Dementia with Lewy Bodies , 2006, The Journal of Neuroscience.

[18]  Wade K. Smith,et al.  Disease‐specific patterns of locus coeruleus cell loss , 1992, Annals of neurology.

[19]  M. Corbetta,et al.  The Reorienting System of the Human Brain: From Environment to Theory of Mind , 2008, Neuron.

[20]  P. Bédard,et al.  Noradrenoceptor antagonism with idazoxan improves l-dopa-induced dyskinesias in MPTP monkeys , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[21]  M. Mesulam,et al.  Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease , 2007, Neurobiology of Aging.

[22]  A. Arnsten,et al.  Adrenergic pharmacology and cognition: focus on the prefrontal cortex. , 2007, Pharmacology & therapeutics.

[23]  Joshua J Gooley,et al.  Neurobiology of the Sleep-Wake Cycle: Sleep Architecture, Circadian Regulation, and Regulatory Feedback , 2006, Journal of biological rhythms.

[24]  C. Berridge Noradrenergic modulation of arousal , 2008, Brain Research Reviews.

[25]  Jonathan D. Cohen,et al.  An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. , 2005, Annual review of neuroscience.

[26]  M. Sarter,et al.  Modulators in concert for cognition: Modulator interactions in the prefrontal cortex , 2007, Progress in Neurobiology.

[27]  Y. Agid,et al.  Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.

[28]  S. Sara,et al.  Network reset: a simplified overarching theory of locus coeruleus noradrenaline function , 2005, Trends in Neurosciences.

[29]  J. D. McGaugh,et al.  Drug enhancement of memory consolidation: historical perspective and neurobiological implications , 2008, Psychopharmacology.

[30]  B D Waterhouse,et al.  New perspectives on the functional organization and postsynaptic influences of the locus ceruleus efferent projection system. , 1998, Advances in pharmacology.